PubMed

The evolution of HIV treatment guidelines: Current state-of-the-art of ART.

Zolopa AR.

Antiviral Res. 2009 Oct 31. [Epub ahead of print]PMID: 19883695 [PubMed - as supplied by publisher]Related articles

Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of life.

Grant PM, Palmer S, Bendavid E, Talbot A, Slamowitz DC, Cain P, Kobayashi SS, Balamane M, Zolopa AR.

J Clin Virol. 2009 Dec;46(4):305-8. Epub 2009 Oct 12.PMID: 19819183 [PubMed - in process]Related articles

Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.

Shahriar R, Rhee SY, Liu TF, Fessel WJ, Scarsella A, Towner W, Holmes SP, Zolopa AR, Shafer RW.

Antimicrob Agents Chemother. 2009 Nov;53(11):4869-78. Epub 2009 Aug 31.PMID: 19721070 [PubMed - in process]Related articles

Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.

Haas DW, Koletar SL, Laughlin L, Kendall MA, Suckow C, Gerber JG, Zolopa AR, Bertz R, Child MJ, Hosey L, Alston-Smith B, Acosta EP; A5213 StudyTeam.

J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):290-3.PMID: 19194314 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study.

DeJesus E, Gottlieb MS, Gathe JC Jr, Greenberg ML, Guittari CJ, Zolopa AR.

Antimicrob Agents Chemother. 2008 Dec;52(12):4315-9. Epub 2008 Sep 22.PMID: 18809940 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.

Acosta EP, Kendall MA, Gerber JG, Alston-Smith B, Koletar SL, Zolopa AR, Agarwala S, Child M, Bertz R, Hosey L, Haas DW.

Antimicrob Agents Chemother. 2007 Sep;51(9):3104-10. Epub 2007 Jun 18.PMID: 17576825 [PubMed - indexed for MEDLINE]Related articlesFree article

N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.

Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Hurley L, Horberg M, Schiffer CA, Zolopa AR, Shafer RW.

AIDS Res Hum Retroviruses. 2006 Dec;22(12):1300-5.PMID: 17209774 [PubMed - indexed for MEDLINE]Related articlesFree article

Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.

Zolopa AR.

J Infect Dis. 2006 Sep 15;194 Suppl 1:S59-64. Review.PMID: 16921474 [PubMed - indexed for MEDLINE]Related articles

Case files from Stanford University Medical Center: the initial presentation of HIV-1 infection--where public and personal health meet.

Liu M, Holodniy M, Zolopa AR, Shafer RW.

MedGenMed. 2006 Jan 26;8(1):24. No abstract available. PMID: 16915154 [PubMed - indexed for MEDLINE]Related articlesFree article

The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.

Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C.

Am J Epidemiol. 2006 May 1;163(9):860-9. Epub 2006 Mar 8.PMID: 16524955 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.

Glesby MJ, Aberg JA, Kendall MA, Fichtenbaum CJ, Hafner R, Hall S, Grosskopf N, Zolopa AR, Gerber JG; Adult AIDS Clinical Trials Group A5159 Protocol Team.

Clin Pharmacol Ther. 2005 Aug;78(2):143-53.PMID: 16084849 [PubMed - indexed for MEDLINE]Related articles

HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.

Rhee SY, Fessel WJ, Zolopa AR, Hurley L, Liu T, Taylor J, Nguyen DP, Slome S, Klein D, Horberg M, Flamm J, Follansbee S, Schapiro JM, Shafer RW.

J Infect Dis. 2005 Aug 1;192(3):456-65. Epub 2005 Jul 5.PMID: 15995959 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection.

Campbell TB, Shulman NS, Johnson SC, Zolopa AR, Young RK, Bushman L, Fletcher CV, Lanier ER, Merigan TC, Kuritzkes DR.

Clin Infect Dis. 2005 Jul 15;41(2):236-42. Epub 2005 Jun 7.PMID: 15983922 [PubMed - indexed for MEDLINE]Related articles

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).

Zolopa AR, Lazzeroni LC, Rinehart A, Vezinet FB, Clavel F, Collier A, Conway B, Gulick RM, Holodniy M, Perno CF, Shafer RW, Richman DD, Wainberg MA, Kuritzkes DR.

Clin Infect Dis. 2005 Jul 1;41(1):92-9. Epub 2005 May 24.PMID: 15937768 [PubMed - indexed for MEDLINE]Related articles

Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine.

Lecossier D, Shulman NS, Morand-Joubert L, Shafer RW, Joly V, Zolopa AR, Clavel F, Hance AJ.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):37-42.PMID: 15608522 [PubMed - indexed for MEDLINE]Related articles

Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study.

Holodniy M, Charlebois ED, Bangsberg DR, Zolopa AR, Schulte M, Moss AR.

Int J STD AIDS. 2004 Aug;15(8):543-51.PMID: 15307966 [PubMed - indexed for MEDLINE]Related articles

Building a better nucleoside/nucleotide analogue backbone: pharmacokinetic and resistance considerations.

Zolopa AR.

AIDS Read. 2003 Sep:S9-15. Review. No abstract available. PMID: 14601554 [PubMed - indexed for MEDLINE]Related articles

Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation.

Gonzales MJ, Delwart E, Rhee SY, Tsui R, Zolopa AR, Taylor J, Shafer RW.

J Infect Dis. 2003 Aug 1;188(3):397-405. Epub 2003 Jul 10.PMID: 12870121 [PubMed - indexed for MEDLINE]Related articlesFree article

Genotype-phenotype discordance: the evolution in our understanding HIV-1 drug resistance.

Zolopa AR.

AIDS. 2003 May 2;17(7):1077-8. No abstract available. PMID: 12700459 [PubMed - indexed for MEDLINE]Related articles

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.

Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou S, Israelski D, Zolopa AR, Fessel WJ, Shafer RW.

J Virol. 2003 Apr;77(8):4836-47.PMID: 12663790 [PubMed - indexed for MEDLINE]Related articlesFree article

Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.

Gonzales MJ, Wu TD, Taylor J, Belitskaya I, Kantor R, Israelski D, Chou S, Zolopa AR, Fessel WJ, Shafer RW.

AIDS. 2003 Apr 11;17(6):791-9.PMID: 12660525 [PubMed - indexed for MEDLINE]Related articlesFree article

Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.

Shulman NS, Hughes MD, Winters MA, Shafer RW, Zolopa AR, Hellmann NS, Bates M, Whitcomb JM, Katzenstein DA.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):121-7.PMID: 12394789 [PubMed - indexed for MEDLINE]Related articles

Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy.

Kantor R, Fessel WJ, Zolopa AR, Israelski D, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW.

Antimicrob Agents Chemother. 2002 Apr;46(4):1086-92.PMID: 11897594 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV drug resistance testing: an update for the clinician.

Rice HL, Zolopa AR.

AIDS Clin Care. 2001 Oct;13(10):89-91, 94-6, 100. No abstract available. PMID: 11590921 [PubMed - indexed for MEDLINE]Related articles

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy.

Shulman NS, Machekano RA, Shafer RW, Winters MA, Zolopa AR, Liou SH, Hughes M, Katzenstein DA; AIDS Clinical Trials Group 302 Study Team.

J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):377-80.PMID: 11468426 [PubMed - indexed for MEDLINE]Related articles

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A.

AIDS. 2001 Jun 15;15(9):1181-3. No abstract available. PMID: 11416722 [PubMed - indexed for MEDLINE]Related articles

Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy.

Shulman N, Zolopa AR, Passaro D, Shafer RW, Huang W, Katzenstein D, Israelski DM, Hellmann N, Petropoulos C, Whitcomb J.

AIDS. 2001 Jun 15;15(9):1125-32.PMID: 11416714 [PubMed - indexed for MEDLINE]Related articles

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Shafer RW, Hertogs K, Zolopa AR, Warford A, Bloor S, Betts BJ, Merigan TC, Harrigan R, Larder BA.

J Clin Microbiol. 2001 Apr;39(4):1522-9.PMID: 11283081 [PubMed - indexed for MEDLINE]Related articlesFree article

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response.

Shulman NS, Zolopa AR, Passaro DJ, Murlidharan U, Israelski DM, Brosgart CL, Miller MD, Van Doren S, Shafer RW, Katzenstein DA.

J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):221-6.PMID: 10839657 [PubMed - indexed for MEDLINE]Related articles

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A.

AIDS. 2000 Mar 10;14(4):357-66.PMID: 10770537 [PubMed - indexed for MEDLINE]Related articles

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed.

Zolopa AR, Shafer RW, Warford A, Montoya JG, Hsu P, Katzenstein D, Merigan TC, Efron B.

Ann Intern Med. 1999 Dec 7;131(11):813-21.PMID: 10610625 [PubMed - indexed for MEDLINE]Related articlesFree article

Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS.

Eckburg PB, Zolopa AR, Montoya JG.

Clin Infect Dis. 1999 Jul;29(1):212-3. No abstract available. PMID: 10433595 [PubMed - indexed for MEDLINE]Related articles

Association between time homeless and perceived health status among the homeless in San Francisco.

White MC, Tulsky JP, Dawson C, Zolopa AR, Moss AR.

J Community Health. 1997 Aug;22(4):271-82.PMID: 9247850 [PubMed - indexed for MEDLINE]Related articles

Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral.

Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR.

Arch Intern Med. 1996 Jan 22;156(2):161-5.PMID: 8546549 [PubMed - indexed for MEDLINE]Related articles

Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients.

Suzuki Y, Wong SY, Grumet FC, Fessel J, Montoya JG, Zolopa AR, Portmore A, Schumacher-Perdreau F, Schrappe M, Köppen S, Ruf B, Brown BW, Remington JS.

J Infect Dis. 1996 Jan;173(1):265-8.PMID: 8537674 [PubMed - indexed for MEDLINE]Related articles

Tuberculosis transmission in methadone maintenance programs.

Hahn JA, Zolopa AR, Moss AR, Trachtenberg AL.

JAMA. 1995 Apr 26;273(16):1260. No abstract available. PMID: 7715037 [PubMed - indexed for MEDLINE]Related articles

HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample.

Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, Pilote L, Moss AR.

JAMA. 1994 Aug 10;272(6):455-61.PMID: 8040981 [PubMed - indexed for MEDLINE]Related articles

Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men.

Zolopa AR, Kemper CA, Shiboski S, Hamilton JR, Moss AR, Deresinski SC.

Clin Infect Dis. 1994 Apr;18(4):636-8.PMID: 8038324 [PubMed - indexed for MEDLINE]Related articles

Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity.

Kemper CA, Zolopa AR, Hamilton JR, Fenstersheib M, Bhatia G, Deresinski SC.

AIDS. 1992 Nov;6(11):1321-5.PMID: 1472336 [PubMed - indexed for MEDLINE]Related articles